
Those classes are: antidepressants antipsychotics anticonvulsants immunosuppressants for treatment of transplant rejection antineoplastics and of utmost important to us HIV-positive long-term survivors, antiretrovirals. Under current rules, all Part D prescription insurance plans must cover all drugs from six protected classes on their formularies. At a time when the Administration is focused on ending the HIV epidemic in the United States by increasing access to HIV drugs for treatment and prevention, allowing such bad medicine would not have made sense.”

“We are pleased that Secretary Azar and the Trump Administration listened to the patients and widely accepted HIV treatment guidelines by rejecting their proposal to institute prior authorization and step therapy for HIV drugs for the first time in the Medicare Part D Program. Carl Schmid, Deputy Executive Director of The AIDS Institute, issued the following statement:
#Hands off medicare series
The PSA is one in a series produced by the San Francisco AIDS Foundation and Precision Strategies out of New York City featuring real Medicare recipients talking about the effects the proposed changes would have on our lives.įortunately, on May 16, 2019, the administration said that it would maintain existing policy for HIV drugs and not allow plans to institute prior authorization and step therapy in the Medicare Part D program. Last month, I filmed a PSA about the devastating changes the Trump-Pence cabal have proposed for Medicare Part D, the prescription drug coverage under Medicare.

Proposed changes to access to lifesaving meds would have killed us
